The antitumour activity of C21 steroidal glycosides and their derivatives of Baishouwu: A review

传统医学 糖苷 中医药 医学 化学 立体化学 病理 替代医学
作者
Xia Zhang,Ming Gao,Zhili Rao,Ziqin Lei,Jiuseng Zeng,Zhangjun Huang,Caihong Shen,Nan Zeng
出处
期刊:Journal of Ethnopharmacology [Elsevier]
卷期号:293: 115300-115300 被引量:8
标识
DOI:10.1016/j.jep.2022.115300
摘要

Baishouwu has been used in China for thousands of years since it was first discovered in the late Tang Dynasty and flourished in the Song and Ming Dynasties. The Chinese herbal medicines named Baishouwu include Cynanchum auriculatum Royle ex Wight., Cynanchum bungei Decne. and Cynanchum wilfordii Hemsl. It is described in the Sign of Materia Medica as "sweet, bitter, reinforce liver and kidney, and non-toxic". It is widely used for nourishing the blood to expel wind, reinforcing liver and kidney, strengthening bones and muscles. In this review, the current research status of the C21 steroidal glycosides and their derivatives of Baishouwu for malignant tumours and their anti-tumour mechanisms are discussed. This may lay the ground for potential application of Baishouwu and its active ingredients in the treatment of tumours. Scientific databases, including PubMed, Elsevier, Science Direct, Google Scholar, CNKI, WANFANG DATA and VIP were searched to gather data about Baishouwu and its C21 steroidal glycosides and their derivatives. Prior literature indicates that Baishouwu has important biological activities such as anti-tumour, anti-epileptic, reducing cholesterol, protection of liver and kidney and immunomodulatory, which are of increasing interest, especially its anti-tumour activity. Recent studies demonstrate that the C21 steroidal glycosides of Baishouwu, which have prominent antitumour efficacy, are one of its main active ingredients. Presently, a variety of C21 steroidal glycosides have been isolated from Baishouwu medicinal part, the tuberous root. This review summarizes the various antitumour activities of the C21 steroidal glycosides and their derivatives of Baishouwu. In this review, the antitumour effects and mechanisms of total C21 steroidal glycosides and monomers and derivatives of Baishouwu in vitro and in vivo were summarized. Baishouwu can inhibit tumourigenesis by blocking tumour cell cycle progression, regulating numerous signaling pathways, promoting apoptosis, inhibiting tumour cells proliferation and metastasis, improving immunity and so on. This review provides a theoretical basis for inheriting and developing the medical heritage of the motherland, exploring the resources of traditional Chinese medicine for ethnic minorities and clinical rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jasmine0211完成签到 ,获得积分10
刚刚
无语子关注了科研通微信公众号
刚刚
闪闪的YOSH完成签到,获得积分10
刚刚
万能图书馆应助好好采纳,获得10
1秒前
暮雨杰泽完成签到 ,获得积分10
1秒前
周围发布了新的文献求助10
1秒前
满家归寻完成签到 ,获得积分10
1秒前
1秒前
李爱国应助国王的宝库采纳,获得10
2秒前
qinyingxin应助郭耀锐采纳,获得10
3秒前
3秒前
keyan发布了新的文献求助10
4秒前
CipherSage应助successful采纳,获得10
4秒前
杨璇发布了新的文献求助10
5秒前
旺仔发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
科研通AI6.3应助猛发sci采纳,获得10
6秒前
6秒前
林齐发布了新的文献求助10
6秒前
6秒前
思源应助高贵振家采纳,获得10
6秒前
田様应助pogia采纳,获得10
7秒前
JamesPei应助Miasanmia采纳,获得10
7秒前
7秒前
小二郎应助月光疾风采纳,获得10
7秒前
果断统统白给完成签到,获得积分10
8秒前
窦鞅发布了新的文献求助10
8秒前
Theft完成签到,获得积分10
8秒前
无语的寒梅完成签到,获得积分10
8秒前
老福贵儿应助白真帅采纳,获得10
9秒前
小魔芋完成签到 ,获得积分10
9秒前
清野发布了新的文献求助10
9秒前
霍仁维思发布了新的文献求助10
11秒前
磷酸瞳发布了新的文献求助10
11秒前
丙队长发布了新的文献求助10
11秒前
bkagyin应助窦鞅采纳,获得10
11秒前
小蘑菇应助李拾玖采纳,获得10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
Social Cognition: Understanding People and Events 1200
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6037471
求助须知:如何正确求助?哪些是违规求助? 7760556
关于积分的说明 16218031
捐赠科研通 5183385
什么是DOI,文献DOI怎么找? 2773973
邀请新用户注册赠送积分活动 1757116
关于科研通互助平台的介绍 1641453